Multi-layer Silicon mold for microneedle manufacturing and manufacturing method thereof
The multilayer silicon mold addresses depth limitations of single-wafer microneedle molds by combining wet- and dry-etched structures, enabling precise and efficient drug delivery with biodegradable tips, suitable for sensitive tissues and continuous drug release.
Patent Information
- Application Number
- KR1020250060124
- Authority / Receiving Office
- KR · KR
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2025-05-09
- Publication Date
- 2026-11-17
AI Technical Summary
Conventional microneedle molds made from single silicon wafers are limited in depth, restricting drug capacity and suitability for specific diseases or targeted therapies.
A multilayer silicon mold is developed by combining a silicon structure with a V-groove shape processed using wet-etching and a silicon structure with a vertical cross-section processed using dry-etching, featuring a lower substrate with a V-groove structure, an air vent hole, and an upper substrate to form a base layer, enabling a depth of approximately 1 mm.
The multilayer mold allows for precise drug delivery to specific target sites with enhanced mechanical strength, biodegradability, and efficient drug release, facilitating rapid skin penetration and minimizing residue, suitable for sensitive tissues and continuous drug release.
Smart Images

Figure PAT00003_ABST
Abstract
Description
Technology Field
[0001] The present invention relates to a mold for producing microneedles and a method for manufacturing the same, and more specifically, to a silicon-to-silicon type microneedle mold having an application depth of approximately 1 mm by joining a silicon structure having a V-groove shape processed using a wet-etching process and a silicon structure having a vertical cross-section processed using a dry-etching process, a method for manufacturing the same, and microneedles produced using the same. Background Technology
[0002] Generally, microneedles are fabricated by creating a mold using a single silicon wafer and then utilizing this mold to construct the needle structure. However, limitations in the thickness of the silicon structure can restrict the depth of application and, consequently, limit the drug capacity that can be loaded. For these reasons, microneedles produced using molds made from single silicon wafers are not suitable for specific diseases or targeted therapies. To address this, research is needed on a method for fabricating molds that combine a silicon structure for drug delivery with an additional structure designed to increase the depth of application. Prior art literature
[0003] Republic of Korea Registered Patent No. 10-0793615 The problem to be solved
[0004] The present invention was devised to overcome these conventional problems, and aims to provide a silicon-to-silicon mold having an application depth of approximately 1 mm by joining a silicon structure having a V-groove shape processed using a silicon wet-etching process (shape ratio 0.7) and a silicon structure having a vertical cross-section processed using a dry-etching process (shape ratio 1), a method for manufacturing the same, and a microneedle manufactured using the same. means of solving the problem
[0005] To achieve the above objectives, the present invention provides a multilayer silicon mold for fabricating microneedles, comprising: a lower silicon substrate formed on the lower part of the mold and including a V-groove structure; an air vent hole formed at the end of the V-groove structure of the lower silicon substrate for air discharge when a liquid material is injected into the mold; an etching groove formed by etching the other side of the mold to a predetermined depth and penetrating the needle processing groove by a predetermined amount to form the air vent hole; and an upper silicon substrate formed on the front surface of the lower silicon substrate to form a base layer of the microneedles.
[0006] In addition, the present invention provides a method for manufacturing a multilayer silicon mold for microneedle fabrication, comprising: (a) a step of depositing an oxide film on both sides of a lower silicon substrate; (b) a step of patterning the oxide film on one side of the lower silicon substrate; (c) a step of performing wet etching on one side of the patterned lower silicon substrate to form a V-groove structure; (d) a step of patterning the oxide film on the other side of the lower silicon substrate for lower etching of the lower silicon substrate; (e) a step of performing etching on the other side of the lower silicon substrate to produce an etching groove and an air vent hole; (f) a step of removing the thermal oxide film on both sides of the lower silicon substrate; and (g) a step of bonding an upper silicon substrate having an opening window having the same diameter as the upper part of the V-groove onto the lower silicon substrate.
[0007] In addition, the present invention provides a microneedle manufactured using the multilayer silicon mold of the present invention, comprising a terminal tip having the shape of a polygonal pyramid and a base layer. Effects of the invention
[0008] The multilayer silicone mold of the present invention enables the fabrication of drug-separating needles by injecting a drug-containing polymer (drug tip) into a silicone structure having a V-groove shape and a polymer to enhance mechanical strength into a base structure. The separation of the drug layer and the base structure allows for the precise delivery of the drug to a specific target site and enables only the drug tip structure to be biodegradable, thereby facilitating the realization of a medical system that possesses not only effective drug delivery but also environmentally friendly characteristics. Furthermore, designing a structure in which a drug is loaded at the tip of a microneedle to enhance the precision and efficiency of drug delivery enables direct delivery of the drug to the target site and provides a system capable of stably releasing an appropriate dose of the drug.
[0009] In addition, the drug-separating microneedle manufactured using the multilayer silicone mold of the present invention can rapidly penetrate the skin barrier (stratum corneum) with minimal force due to the pointed tip of the drug layer and the angular structure of the basal layer, thereby providing strong penetration power into the skin and delivering the drug to the target site within a short period of time. Structurally, the drug is delivered to deeper layers, and the polygonal structure of the basal layer can increase the strength of the microneedle and increase the likelihood of use without damage. The drug-separating microneedle manufactured using the multilayer silicone mold is inserted into a localized area to effectively deliver the drug, and is designed so that the basal layer can be separated after insertion, thereby maximizing user convenience and safety. Local treatment is possible without residue by removing the basal layer while maintaining the stability of the inserted drug layer; it is particularly suitable for treatments requiring sensitive tissues or continuous drug release, and offers potential applications in medical environments where residue management after insertion is critical. Brief explanation of the drawing
[0010] Figure 1 is a conceptual cross-sectional view of a drug separation type microneedle fabricated using the multilayer silicone mold of the present invention. FIG. 2 is a cross-sectional view showing the manufacturing process of a multilayer silicon mold for manufacturing microneedles of the present invention. FIG. 3 shows an image of a multilayer silicone mold of the present invention: (a) front side, (b) rear air vent hole (width 3 μm × height 3 μm). FIG. 4 is an image of a microneedle fabricated using the multilayer silicon mold of the present invention: (a) full isometric, (b) full frontal, (c) single isometric, (d) single frontal and numerical. Specific details for implementing the invention
[0011] Hereinafter, preferred embodiments of the present invention will be described in detail with reference to the attached drawings. However, the present invention is not limited to the embodiments disclosed below but may be implemented in various different forms, and these embodiments are provided merely to ensure that the disclosure of the present invention is complete and to fully inform those skilled in the art of the scope of the invention.
[0012] The present invention relates to a multilayer silicone mold for microneedle fabrication and a method for manufacturing the same.
[0013] As illustrated in FIG. 3, the multilayer silicon mold of the present invention comprises: a lower silicon substrate formed at the bottom of the mold and including a V-groove structure; an air vent hole formed at the end of the V-groove structure of the lower silicon substrate for air discharge when a liquid material is injected into the mold; an etching groove for forming the air vent hole by etching the other side of the mold to a predetermined depth and penetrating the needle processing groove by a predetermined amount; and an upper silicon substrate formed on the front surface of the lower silicon substrate to form a base layer of the microneedle.
[0014] The V-groove structure of the lower silicon substrate is formed in the shape of a polygonal horn, and the air vent hole is formed at the end of the horn, thereby resolving the problem of not being able to achieve a perfect needle shape due to air bubbles (air bubble capture phenomenon) at the tip of the needle shape when a liquid substance is injected.
[0015] In the above multilayer silicone mold, the lower silicone structure having a V-groove shape has an aspect ratio of 0.7, and the upper silicone structure having a vertical cross-section is manufactured to have an aspect ratio of 1, so that it can have an application depth of ~1 mm and an aspect ratio of 1.7.
[0016] The above multilayer silicon mold is manufactured to have an application depth of approximately 1 mm in the form of silicon-to-silicon by joining a lower silicon structure having a V-groove shape processed using a silicon wet-etching process and a silicon structure having a vertical cross-section processed using a dry-etching process, and can be manufactured, for example, by a manufacturing process as shown in FIG. 2.
[0017] The manufacturing process of the multilayer silicon mold of the present invention is as follows.
[0018] First, oxide films (20)(30) are deposited on both sides of the lower silicon wafer (10) (a).
[0019] Afterwards, the oxide film on one side of the lower silicon wafer is patterned (b).
[0020] Wet etching is performed on one side of the patterned (22) lower silicon wafer to form a V-groove structure (12) (c). Here, the wet etching is characterized by being performed using KOH.
[0021] Afterwards, the oxide film on the other side of the lower silicon wafer is patterned for lower etching of the lower silicon wafer (d).
[0022] Etching is performed on the other side of the lower silicon wafer to create an etching groove (14) and an air vent hole (40) (e). For example, after forming an etching groove (14) by performing wet etching on the other side of the lower silicon wafer, additional dry etching can be performed to create an air vent hole (40).
[0023] After performing a double-sided etching process on the lower silicon wafer for mold fabrication, the thermal oxide film is removed (f), and, for example, the thermal oxide film can be removed using BOE.
[0024] Then, an upper silicon substrate including an opening window having a diameter equal to the diameter of the upper portion of the V-groove is bonded onto the lower silicon substrate (g). The upper silicon substrate may be fabricated by dry etching a silicon wafer using an RIE process. The size of the opening may be 500 μm in width and 500 μm in height, and the upper silicon substrate may have a thickness of 400 to 600 μm, for example, 500 μm. The aspect ratio can be controlled by adjusting the thickness of the upper silicon substrate.
[0026] In addition, the present invention relates to a microneedle manufactured using a multilayer silicone mold and comprising a terminal tip having the shape of a polygonal pyramid and a base layer.
[0027] The microneedles of the present invention can be manufactured using a soluble polymer. For example, drug-separating microneedles can be manufactured by injecting the same soluble polymer into the entire mold, or by injecting a drug-containing polymer (drug tip) into a silicon structure having a V-groove shape and injecting a polymer to increase mechanical strength into a glass base structure.
[0028] The above-described microneedle may be a drug-separating microneedle in which the terminal tip comprises a biodegradable polymer containing a drug and the base layer comprises a polymer with high mechanical strength. In the drug-separating microneedle, the terminal tip containing the drug is inserted into a local site, and the base layer is separated so that the drug is accurately delivered to a specific target site and only the drug tip structure can be biodegraded.
[0029] The above-mentioned biodegradable polymer may be used without limitation if it is a biodegradable polymer used in the pharmaceutical field, for example, Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polylactic-co-Glycolic Acid (PLGA), Polycaprolactone (PL), Polyhydroxybutyrate (PHB), Polyhydroxybutyrate-co-Valerate (PHBV), Polylactide-co-Glycolide-co-Caprolactone (PLGC), Polybutylene Succinate (PBS), Polybutylene Adipate-co-Terephthalate (PBAT), Chitosan, Hyaluronic Acid, HA), Carboxymethyl Cellulose (CMC), Gelatin, Dextran, Alginate, Hydroxypropyl Methylcellulose (HPMC), Hydroxyethyl Cellulose (HEC), Cellulose Acetate Phthalate (CAP), Polyglycerol Sebacate (PGS), Polydioxanone (PDO), Polytrimethylene Carbonate (PTMC), Polypropylene Carbonate (PPC), Polyglutamic Acid, Polyacrylic Acid (PAA),Pectin, Glucomannan, Hydroxypropyl Starch, Guar Gum, Zein, Albumin-Based Polymers, Fibrinogen, Vitamin E-Based Polymers, Polyhydroxyalkanoates (PHA), Polycaprolactone Diol, Polylactic Acid Diol, Polyglycolic Acid Diol, Polytrimethylene Adipate, Polytetrahydrofuran (PTHF), Polylactone Cellulose, Polylinoleic Acid Glycerol, Polyglucosamine, Polyoxacellulose, Polyglycerol, Polylactoco-Caprolactone, Polyhydroxybutyrate-co-Hydroxyhexanoate (PHBH), Polyhydroxybutyrate-co-Glycolic Acid, Polydioxanol, Polyglucose Lactone, Polytetramethylene Oxide, Polydimethyldioxaneate, Polyglutarimide, Polyoxadiazole, Polytrifluoroethylene, Polyallylglycol,Polyglycerol Sebacate-co-Lactide (PGSL), Polylactide-co-Glycerol Adipate, Polyoxypropylene Glycol, Polyglycerol Ester, Polypropylene Oxide, Polyacetate, Polyvinyl Chloride-co-Maleic Acid, Polydimethylsiloxane (PDMS; Biodegradable Derivatives), Polylactide-co-Dioxanone, Polytetrafluoroethylene, Polybutylene-co-Caprolactone, Polypropylene Carbonate-co-Lactide Carbonate-co-Lactide), Polyoxycellulose, Polylactone-co-Hydroxybutyrate, Polycaprolactone-co-Hydroxybutyrate, Polyglycerol Sebacate-co-Caprolactone, Polylactic Acid-co-Caprolactone, Polypropylene-co-Lactide, Polytrifluorochloroethylene, Polylactide-co-Glycerol Adipate, Polytrimethylene Adipate,Polyallylamine Hydrochloride, Polylactide-co-Methyl Lactone, Polycaprolactone-co-Hexanoate, Polybutylene Adipate-co-Terephthalate, Polytetrahydrofuran Diol, Polyglycerol Acrylate,
[0030] Polybutylene Glycerol Ester, Polydimethyldioxaneate, Polyhexamethylene Adipate, Polytetrahydrofurandiol-co-Lactide, Polylactide-co-Dioxanone-co-Terephthalate, Polyoxadiazole-co-Lactide, Polydimethyloxazole, Polytetramethylene Oxide-co-Lactide, Polybutylene Oxide, Polycaprolactone-co-Terephthalate, Polyallylactide Lactide), Polylinoleic Ester, Polycarboxymethyl Lactone, Polyglycerol Dimethacrylate, Polypropylene Glycerol Ester, Polylactic Acid-co-Hydroxybutyrate, Polycaprolactone-co-Propylene Carbonate, Polylactone-co-Furanyl Lactone, Polytrimethylene-co-Lactide, Polyglycerol-co-Adipate, Polycarboxylated Glycerol, Polymethyl Lactone Diol,Polyglutaryl Lactone, Polybutyl Lactone, Polyvinyl Caprolactone, Polylactide-co-Terephthalate, Polyvinyl Acetate-co-Lactide, Polybutylene Lactone-co-Glycerol, Polyoxohexanoate, Polytetrafluorolactone, Polycaprolactone Diol-co-Lactide, Polytrifluorolactone-co-Glycerol, Polyglycerol Sebacate-co-Butyl Lactone, Polylactide-copropylene oxide (Polylactide-co-Propylene Oxide), Polymethoxy Lactone, Polybutylene-co-Glycerol Lactone, Polylinoleic Acid Glycerol Ester, Polybutylene Adipate-co-Terephthalate, Polyhexanoate-co-Terephthalate, Polyglycerol-co-Lactone, Polydimethylsiloxane-co-Lactide, Polycaprolactone-co-Hexanoate, Polypropylene Oxide-co-Lactide, Polyglycerol Epoxide (Polyglycerol Epoxide),Polybutyl Lactide-co-Dioxanone, Polymethoxy Lactide, Polyallyl Lactone, Polyoxolactone-co-Hexanoate, Polybutylene Adipate-co-Lactide, Polyglycerol Diacrylate, Polyglycerol Ester-co-Lactide, Polybutylene Glycerol Ester, Polylactide-co-Hexanoate, Polybutylene Oxide-co-Lactide, Polyhexanoate Diol-co-Lactide It may be selected from the group consisting of polyhexanoate diol-co-lacide, polyoxolactone-co-butylene adipate, polybutylene adipate-co-lactide, and combinations thereof.
[0032] The above-mentioned polymer with high mechanical strength may be used without limitation if it is a polymer used in this field, for example, Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polylactic-co-Glycolic Acid (PLGA), Polycaprolactone (PL), Polyhydroxybutyrate (PHB), Polyhydroxybutyrate-co-Valerate (PHBV), Hyaluronic Acid (HA), Gelatin, Polylactide-co-Caprolactone (PLCL), Polybutylene Succinate (PBS), Polydioxanone (PDO), Polytrimethylene Carbonate (PTMC), It may be selected from the group consisting of polylactic acid-co-glycerol sebacate (PLAGS), polybutylene adipate-co-terephthalate (PBAT), polyglycerol sebacate (PGS), polytrimethylene lacone, polylactide-co-dioxanone, polyglycerol-co-adipate, polylactic acid diol, polylactic acid-co-hexanoate, and combinations thereof.
[0033] The above drug-isolating microneedles can be applied directly to a target site through local drug delivery, and can minimize side effects and increase treatment efficiency by directly delivering drugs to, for example, skin diseases such as acne and psoriasis or cancer tissues.
[0035] <Example>
[0036] Example 1. Multilayer silicone mold
[0037] A multilayer silicone mold was fabricated through the process as shown in Fig. 2.
[0038] After depositing a thermal oxide film on both sides of a silicon wafer (a), a selective patterning process of the thermal oxide film was performed on the front side of the silicon wafer to create a V-groove through a photolithography process (b). The body of the silicon substrate was processed by wet etching using KOH (c). To etch the bottom of the needle mold, the thermal oxide film on the back side of the silicon wafer was patterned (d), and an air vent hole (3㎛×3㎛) was created by wet etching (e). Then, the thermal oxide film used as an etching protection layer was removed using BOE (f). Dry etching of a silicon wafer with a thickness of 500㎛ was performed using an RIE process (g). The opening window size was 500㎛ in width and height, and two processed silicon wafers were aligned and bonded to fabricate a mold structure.
[0039] Figure 3 is an image showing a fabricated multilayer silicone mold, where it can be seen that an air vent hole is formed.
[0041] Example 2. Microneedle fabrication
[0042] Polymer preparation
[0043] Gelatin was used as the polymer, and the mixing was carried out in the following order.
[0044] A 35% w / v gelatin mixed solution was prepared by mixing 26 mL of distilled water (Samjeon Soonyak Industrial Co., Ltd.) with 14 g of gelatin, and a 3% w / v HA solution was prepared by mixing 50 mL of distilled water with 1.5 g of HA (Hyaluronic acid, Sigma-Aldrich), and then stored in a 50 mL Polypropylene Conical Tube (30 × 115 mm, FALCON). A syringe (10 mL Disposable syringe, Korea Vaccine) was used to weigh the distilled water, and the weights of the gelatin and liquid gelatin were measured using a precision electronic balance (XT 200A, Precisa). A 35% w / v gelatin solution and a 3% w / v HA solution were uniformly mixed using S / T Spoons (Koryo Ace Science), and then dissolved in a constant temperature water bath (Water bath, VS-1205WP, VISION SCIENTIFIC CO. LTD) at 60°C until the bubbles disappeared. The prepared gelatin mixture solution was stored in a constant temperature water bath at 60°C, and the prepared HA solution was stored at room temperature.
[0046] Microneedle fabrication
[0047] After applying 0.3 mL of methanol (Sigma-Aldrich) to the mold, negative pressure (80 kPa) and positive pressure (0 kPa) were alternately applied once for 2 minutes in a vacuum chamber. Subsequently, 0.1 mL of 3% w / v HA solution was applied to the entire mold, and negative pressure (80 kPa) and positive pressure (0 kPa) were alternately applied three times for 2 minutes in a vacuum chamber. After applying 0.15 mL of 25% w / v gelatin solution to the mold, negative pressure (80 kPa) and positive pressure (0 kPa) were alternately applied once for 2 minutes in a vacuum chamber. Afterward, the mold was dried at 60 ℃ for 30 minutes using a forced circulation dryer (OF-02, Jiotec). 1 mL of a 25% w / v gelatin solution was added to the mold, and negative pressure (80 kPa) and positive pressure (0 kPa) were alternately applied once for 2 minutes in a vacuum chamber. Afterward, the microneedles were dried at 30 ℃ for 2 hours using a forced-circulation dryer. After completing all drying processes, the microneedles were separated from the mold.
[0049] Table 1 shows the dimensions of the fabricated microneedles, confirming that microneedles with an application depth of approximately 1 mm and an aspect ratio of 1.69 were manufactured. The volume of the terminal tips of the polygonal horn or pyramid-shaped microneedles, which can be used as a drug layer, is 4.30 × 10⁻⁶. -8 With sufficient drug storage space in mL, high-dose drug infusion is possible in a short period of time.
[0050]
[0051] Figure 4 is an image of a microneedle fabricated with a multilayer silicone mold. The formation of a pyramid-shaped top of the microneedle (drug tip) and a vertical cross-sectional bottom of the microneedle (base layer) can be observed.
[0053] The rights of the present invention are not limited to the embodiments described above but are defined by the claims, and it is obvious that a person skilled in the art may make various modifications and adaptations within the scope of the rights described in the claims. Explanation of the symbols
[0054] 10: Lower silicon substrate 12: V-groove 14: Etching groove 20, 30: Oxide film 40: Air vent hole 50: Upper silicon substrate
Claims
Claim 1 A multilayer silicon mold for fabricating microneedles, comprising: a lower silicon substrate formed on the lower part of the mold and including a V-groove structure; an air vent hole formed at the end of the V-groove structure of the lower silicon substrate for air discharge when a liquid material is injected into the mold; an etching groove formed by etching the other side of the mold to a predetermined depth and penetrating the needle processing groove by a predetermined amount to form the air vent hole; and an upper silicon substrate formed on the front surface of the lower silicon substrate to form a base layer of the microneedles. Claim 2 A multilayer silicon mold for fabricating microneedles according to claim 1, wherein the V-groove structure of the lower silicon substrate is formed in the shape of a polygonal pyramid, and the air vent hole is formed at the end of the pyramid. Claim 3 A multilayer silicon mold for microneedle fabrication according to claim 1, wherein the upper silicon substrate comprises an opening window having a diameter equal to the diameter of the upper portion of the V-groove. Claim 4 (a) a step of depositing an oxide film on both sides of a lower silicon substrate; (b) a step of patterning the oxide film on one side of the lower silicon substrate; (c) a step of performing wet etching on one side of the patterned lower silicon substrate to form a V-groove structure; (d) a step of patterning the oxide film on the other side of the lower silicon substrate for lower etching of the lower silicon substrate; (e) a step of performing etching on the other side of the lower silicon substrate to produce an etching groove and an air vent hole; (f) a step of removing a thermal oxide film on both sides of the lower silicon substrate; and (g) a step of bonding an upper silicon substrate having an opening window having the same diameter as the upper part of the V-groove onto the lower silicon substrate; comprising a method for manufacturing a multilayer silicon mold for microneedle fabrication. Claim 5 A method for manufacturing a multilayer silicon mold for microneedle fabrication according to claim 4, wherein the upper silicon substrate is fabricated by dry etching a silicon wafer using an RIE process. Claim 6 A microneedle manufactured using a multilayer silicone mold according to any one of claims 1 to 3, comprising a terminal tip having the shape of a polygonal pyramid and a base layer. Claim 7 In claim 6, the microneedles are drug-separating type microneedles. Claim 8 A microneedle according to claim 7, wherein the terminal tip comprises a biodegradable polymer containing a drug, and the base layer comprises a polymer having high mechanical strength. Claim 9 In claim 7, the microneedle, wherein the terminal tip containing the above drug is inserted into a local site and the base layer is separated.
